Partial Tracheal Defects Closure using Glutaraldehyde-Treated Autologous Pericardium.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Surgical Innovation

Background:

• The efficacy of glutaraldehyde-treated autologous pericardium for tracheal defect repair remains uninvestigated.
• Tracheal defects pose significant surgical challenges requiring effective reconstructive materials.

Purpose of the Study:

• To evaluate the effectiveness of glutaraldehyde-treated autologous pericardial grafts in closing tracheal defects in a canine model.
• To compare the healing and graft performance of treated versus untreated pericardium.

Main Methods:

• Ten beagles underwent creation of 10x10mm tracheal defects, randomly assigned to receive either glutaraldehyde-treated (n=5) or fresh (n=5) autologous pericardial grafts.
• Repair sites were assessed via bronchoscopy and histology, with graft blood flow monitored using laser Doppler.
• Long-term histological evaluation of treated grafts was performed at 12 months post-surgery.

Main Results:

• Glutaraldehyde-treated pericardium significantly reduced suturing time and the need for additional sutures compared to fresh pericardium (p<0.01).
• The treated group exhibited minimal graft contraction and enhanced reepithelialization, unlike the control group which showed significant contraction (p<0.01).
• Laser Doppler confirmed blood flow in treated grafts from postoperative day 14 onwards; long-term histology showed residual grafts with reepithelialization and no contraction.

Conclusions:

• Glutaraldehyde-treated autologous pericardium is easier to handle and provides superior scaffolding for tracheal defect closure.
• The treated pericardium demonstrates favorable short- and long-term outcomes, preventing graft contraction and promoting reepithelialization.